(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 26.27% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.18%.
Hyperfine's revenue in 2026 is $13,563,000.On average, 3 Wall Street analysts forecast HYPR's revenue for 2026 to be $1,798,503,556, with the lowest HYPR revenue forecast at $1,727,974,004, and the highest HYPR revenue forecast at $1,851,400,719. On average, 3 Wall Street analysts forecast HYPR's revenue for 2027 to be $2,128,229,207, with the lowest HYPR revenue forecast at $2,044,769,239, and the highest HYPR revenue forecast at $2,190,824,184.
In 2028, HYPR is forecast to generate $2,427,979,800 in revenue, with the lowest revenue forecast at $2,332,764,906 and the highest revenue forecast at $2,499,390,971.